The ALDH2 polymorphism, particularly the ∗2 allele (rs671, Glu504Lys), has emerged as a critical genetic factor influencing the clinical and translational aspects of CAD, especially in high‐prevalence regions such as East Asia and other populations with significant carrier frequencies [21, 22]. This evidence concerns the gene ALDH2 and coronary artery disorder.